Clinical Study

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis

Table 2

Multivariate analysis of independent prediction of NAFLD with transaminitis.

VariableOdds ratio value95% confidence interval
LowerUpper

Cumulative methotrexate1.0350.0150.0921.051
Methotrexate dose0.9440.3370.8401.062
Fasting blood Sugar0.5640.1290.2701.180